Literature DB >> 3340297

Neuroleptic malignant syndrome: caffeine contracture of single muscle fibers and muscle pathology.

M Araki1, A Takagi, I Higuchi, H Sugita.   

Abstract

The neuroleptic malignant syndrome (NMS) is similar to anesthesia-induced malignant hyperthermia (MH) in three major clinical features: hyperthermia, muscular rigidity, and myoglobinuria. In eight cases of NMS, we studied caffeine contracture of single skinned muscle fibers. Sensitivity of the sarcoplasmic reticulum to caffeine was abnormally increased in six of the eight cases. Morphologic studies showed type 2B fiber atrophy in all six cases examined, and there were necrotic fibers in two cases. Since skeletal muscle is affected in NMS, these patients may be susceptible to MH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340297     DOI: 10.1212/wnl.38.2.297

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.

Authors:  Rebecca E Anglin; Patricia I Rosebush; Michael F Mazurek
Journal:  CMAJ       Date:  2010-08-09       Impact factor: 8.262

2.  Anesthetic management of a pediatric patient with neuroleptic malignant syndrome.

Authors:  Tarun Bhalla; Douglas Maxey; Amod Sawardekar; Joseph D Tobias
Journal:  J Anesth       Date:  2011-11-19       Impact factor: 2.078

3.  Neuroleptic malignant syndrome: a review.

Authors:  R A O'Brien; G B Young
Journal:  Can Fam Physician       Date:  1989-05       Impact factor: 3.275

4.  Effects of chlorpromazine on excitation-contraction coupling events in fast-twitch skeletal muscle fibres of the rat.

Authors:  R Wagner; R H A Fink; D G Stephenson
Journal:  Br J Pharmacol       Date:  2004-01-19       Impact factor: 8.739

Review 5.  Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury.

Authors:  S Lee; A Merriam; T S Kim; M Liebling; D W Dickson; G R Moore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

6.  Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?

Authors:  D Kelly; S J Brull
Journal:  Can J Anaesth       Date:  1994-09       Impact factor: 5.063

Review 7.  Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.

Authors:  Lurdes Tse; Alasdair M Barr; Vanessa Scarapicchia; Fidel Vila-Rodriguez
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.